Valuation dashboard for Plus Therapeutics, Inc. (PSTV) with P/E N/A, P/B 4.80, EV/EBITDA -1.74 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses.
Analysis Summary
Plus Therapeutics, Inc. reported revenue of $5.2M in the most recent fiscal year, growing at a 5-year CAGR of 76.7%.
Trailing-twelve-month margins: gross margin 61.5%, operating margin -6.3%, net margin -6.2%.
At the current price of $3.87, PSTV has negative trailing earnings (P/E not meaningful) and an ROE of -5.60%. Market capitalisation stands at $9M.
Balance sheet quality for PSTV: current ratio of 1.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 4.80 |
| EV / EBITDA | -1.74 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.13 |
| vs Current Price | -96.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| PSTV | Plus Therapeutics, Inc. | $9M | 4.80 | -5.6% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $3.87 |
| Market Cap | $9M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -560.21% |
| Return on Invested Capital | -317.58% |
| Return on Assets | -137.13% |
| Gross Margin | 61.53% |
| Operating Margin | -628.12% |
| Net Margin | -620.70% |
Related companies: ADTX · BXRXQ · EDSA · MTVA · PHIO · RKTO
Explore sector: Healthcare · Biotechnology
More sections of PSTV: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks